
Improved Responses to Pegylated Interferon Alfa-2b and Ribavirin by Individualizing Treatment for 24-72 Weeks
Keywords: پاسخ پایدار ویروسی; Viral Kinetics; Liver Disease; Clinical Trial; Dosage; GGT; γ-glutamyltransferase; IL; interleukin; SVR; sustained virologic response; TMA; transcription-mediated amplification;